Metall Zug Valuation
Is METN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of METN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: METN (CHF1135) is trading above our estimate of fair value (CHF565.7)
Significantly Below Fair Value: METN is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for METN?
Key metric: As METN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is METN's PE Ratio? | |
|---|---|
| PE Ratio | 7.5x |
| Earnings | CHF 68.51m |
| Market Cap | CHF 510.75m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.4x |
| Enterprise Value/EBITDA | 7.9x |
| PEG Ratio | -0.3x |
Price to Earnings Ratio vs Peers
How does METN's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 74.3x | ||
MED Medartis Holding | 161.9x | 51.7% | CHF 652.6m |
MOVE Medacta Group | 42.6x | 18.4% | CHF 2.2b |
STMN Straumann Holding | 61.3x | 20.9% | CHF 17.6b |
SOON Sonova Holding | 31.4x | 8.7% | CHF 18.9b |
METN Metall Zug | 7.5x | -29.6% | CHF 510.8m |
Price-To-Earnings vs Peers: METN is good value based on its Price-To-Earnings Ratio (7.5x) compared to the peer average (74.3x).
Price to Earnings Ratio vs Industry
How does METN's PE Ratio compare vs other companies in the European Medical Equipment Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: METN is good value based on its Price-To-Earnings Ratio (7.5x) compared to the European Medical Equipment industry average (29.7x).
Price to Earnings Ratio vs Fair Ratio
What is METN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 7.5x |
| Fair PE Ratio | 10.2x |
Price-To-Earnings vs Fair Ratio: METN is good value based on its Price-To-Earnings Ratio (7.5x) compared to the estimated Fair Price-To-Earnings Ratio (10.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
COLTENE Holding
CHF 305.9m
Develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania.
CLTN
CHF 51.20
7D
-6.2%
1Y
-23.6%
Becton Dickinson
US$66.7b
Develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
912061
US$238.02
7D
0%
1Y
-2.2%
Galenica
CHF 3.8b
Operates as a healthcare service provider in Switzerland and internationally.
GALE
CHF 76.30
7D
-0.5%
1Y
8.2%